🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 1 día
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
16/05/2011 2,5000 EUR
20/05/2010 2,4000 EUR
23/04/2009 2,2000 EUR
16/05/2008 2,0700 EUR
07/06/2007 1,7500 EUR
29/11/2006 0,2668 EUR
07/06/2006 1,5200 EUR
29/11/2005 0,2409 EUR
07/06/2005 1,2000 EUR
30/09/2004 0,0750 EUR
05/05/2004 1,4550 EUR
02/06/2003 0,8400 EUR
03/06/2002 0,6600 EUR
01/06/2001 0,4400 EUR
05/06/2000 0,3200 EUR
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/12/2025 82,42 83,12 81,60 82,10 -0,02% 1,84% 1.980.683
17/12/2025 80,50 82,12 80,32 82,12 +1,46% 2,24% 1.928.662
16/12/2025 82,27 82,30 80,71 80,94 +0,42% 1,93% 2.186.982
15/12/2025 78,40 82,78 78,00 80,60 -3,26% 6,10% 3.831.003
12/12/2025 83,05 83,92 83,05 83,32 -0,38% 1,05% 1.808.314
11/12/2025 82,48 83,88 82,34 83,64 +1,16% 1,87% 1.744.922
10/12/2025 82,80 83,16 82,30 82,68 -0,66% 1,04% 2.362.119
09/12/2025 83,79 83,89 82,00 83,23 -0,44% 2,26% 1.937.799
08/12/2025 84,43 85,04 83,06 83,60 -1,65% 2,35% 1.912.105
05/12/2025 84,30 85,86 84,30 85,00 +0,51% 1,85% 2.004.635
04/12/2025 85,30 85,50 84,43 84,57 -1,25% 1,25% 2.217.125
03/12/2025 85,99 86,78 85,11 85,64 -0,59% 1,94% 1.447.788
02/12/2025 86,21 87,25 85,95 86,15 -0,51% 1,51% 1.205.255
01/12/2025 85,42 86,76 85,24 86,59 +0,97% 1,78% 2.021.650
28/11/2025 86,13 86,28 85,52 85,76 -0,15% 0,88% 1.255.360
27/11/2025 86,02 86,35 85,48 85,89 -0,39% 1,01% 983.046
26/11/2025 87,19 87,43 85,50 86,23 -0,19% 2,21% 1.598.183
25/11/2025 86,00 87,57 85,13 86,39 +0,51% 2,84% 2.530.813
24/11/2025 86,80 86,87 85,38 85,95 -0,43% 1,72% 2.795.567
21/11/2025 85,25 86,50 85,12 86,32 +1,17% 1,62% 2.095.419
20/11/2025 86,41 86,66 85,32 85,32 -0,72% 1,55% 2.370.262
19/11/2025 87,68 87,71 85,94 85,94 -1,87% 2,02% 2.481.800
18/11/2025 89,29 89,69 87,07 87,58 -2,57% 2,93% 2.533.837
17/11/2025 89,42 90,07 89,36 89,89 +0,33% 0,79% 1.054.262
14/11/2025 89,92 90,28 89,22 89,59 -0,94% 1,18% 1.512.508
13/11/2025 90,13 90,79 89,24 90,44 +0,34% 1,72% 1.560.576
12/11/2025 89,50 90,65 89,29 90,13 +1,21% 1,52% 1.816.316
11/11/2025 87,90 89,29 87,56 89,05 +2,58% 1,97% 1.071.549
10/11/2025 85,70 87,14 85,53 86,81 +1,60% 1,88% 1.147.091
07/11/2025 85,89 86,14 85,05 85,44 -0,20% 1,27% 1.047.635